ArticleJournal of medical case reports2017

Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.

Vineet Kwatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.